Pharmacodynamic effects of semorinemab on plasma and CSF biomarkers of Alzheimer's disease pathophysiology. - Schauer SP; Toth B; Lee J; Honigberg LA; Ramakrishnan V; Jiang J; Kollmorgen G; Bayfield A; Wild N; Hoffman J; Ceniceros R; Dolton M; et al. (Alzheimer's & dementia : the journal of the Alzheimer's Association, 2024)